Personal information

Websites & social links

Academic web-page

Other IDs

ResearcherID: A-9136-2012
Scopus Author ID: 35190313500

Keywords

bioinformatics, computational biology, machine learning, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, network analysis, pathway analysis, biostatistics, systems biology, text mining, virtual screening, gender differences, aging

Countries

Luxembourg

Activities

Collapse all

Employment (8)

University of Luxembourg: Luxembourg, LU

2018 to present | Assistant Professor (Luxembourg Centre of Systems Biomedicine)
Employment
Source: Self-asserted source
Enrico Glaab

University of Luxembourg: Esch-sur-Alzette, LU

2017-02-01 to 2018 | Senior Research Scientist (Luxembourg Centre for Systems Biomedicine)
Employment
Source: Self-asserted source
Enrico Glaab

University of Luxembourg: Esch-sur-Alzette, LU

2015-10-01 to 2017-01-31 | Research Scientist (Luxembourg Centre for Systems Biomedicine)
Employment
Source: Self-asserted source
Enrico Glaab

University of Luxembourg: Esch-sur-Alzette, LU

2011-09-01 to 2015-10-01 | Research Associate, supervisor: Dr. Reinhard Schneider (Luxembourg Centre for Systems Biomedicine)
Employment
Source: Self-asserted source
Enrico Glaab

European Molecular Biology Laboratory: Heidelberg, Baden-Württemberg, DE

2011-05-01 to 2011-09-01 | Short-Term Fellowship by the German Academic Exchange Service (DAAD), supervisor: Dr. Reinhard Schneider (Structural and Computational Biology Unit)
Employment
Source: Self-asserted source
Enrico Glaab

University of Nottingham: Nottingham, Nottinghamshire, GB

2007-10 to 2011-05 | PhD in Computer Science / Bioinformatics (Department of Computer Science)
Employment
Source: Self-asserted source
Enrico Glaab

University of Nottingham: Nottingham, Nottinghamshire, GB

2009 to 2010 | EPSRC Research Fellow (Department of Computer Science)
Employment
Source: Self-asserted source
Enrico Glaab

University of Nottingham: Nottingham, Nottinghamshire, GB

2007 to 2009 | Marie Curie Research Fellow (Department of Computer Science)
Employment
Source: Self-asserted source
Enrico Glaab

Education and qualifications (3)

University of Nottingham: Nottingham, Nottingham, GB

2007-10-01 to 2011-05-01 | PhD in Computer Science / Bioinformatics (Computer Science)
Education
Source: Self-asserted source
Enrico Glaab

Saarland University: Saarbrücken, DE

2006-06-01 to 2007-10-01 | MSc. in Computational Molecular Biology (Honours Degree)
Education
Source: Self-asserted source
Enrico Glaab

Saarland University: Saarbrücken, DE

2003-10-01 to 2006-06-01 | BSc. in Computational Molecular Biology
Education
Source: Self-asserted source
Enrico Glaab

Professional activities (18)

Studienstiftung des deutschen Volkes eV: Bonn, Nordrhein-Westfalen, DE

Alumni Association of the German National Merit Foundation
Membership
Source: Self-asserted source
Enrico Glaab

International Society for Computational Biology: La Jolla, CA, US

Membership
Source: Self-asserted source
Enrico Glaab

German Informatics Society: Bonn, DE

Membership
Source: Self-asserted source
Enrico Glaab

FP7 People: Marie-Curie Actions: Brussels, BE

Marie Curie Alumni Association
Membership
Source: Self-asserted source
Enrico Glaab

European Molecular Biology Laboratory Hamburg: Hamburg, Hamburg, DE

European Molecular Biology Laboratory (EMBL) Alumni Association
Membership
Source: Self-asserted source
Enrico Glaab

LongHack: Helsinki, FI

2021 | Winning team at the international coding challenge on longevity research “LongHack”
Distinction
Source: Self-asserted source
Enrico Glaab

SBV (Systems Biology Verification) IMPROVER challenge: New York, US

2020 | Prize for Best Performing Entrant in Metagenomics Diagnosis for Inflammatory Bowel Disease Challenge (MEDIC)
Distinction
Source: Self-asserted source
Enrico Glaab

Active Motif Inc: Carlsbad, CA, US

2019 | Winner of the international Active Motif Grant Competition
Distinction
Source: Self-asserted source
Enrico Glaab

Bayer-Stiftungen: Leverkusen, DE

2015 | • Bayer Lindau Fellowship 2015 - chosen by the Lindau selection committee for participation in the Lindau Nobel Laureate Meeting 2015, Germany
Distinction
Source: Self-asserted source
Enrico Glaab

Geoffrey Beene Foundation: New York, New York, US

2013 | Winner of the international Geoffrey Beene Alzheimer’s Global NeuroDiscovery Challenge
Distinction
Source: Self-asserted source
Enrico Glaab

Benelux Bioinformatics Conference: Nijmegen, NL

2012 | • Poster Prize Award at the Benelux Bioinformatics Conference
Distinction
Source: Self-asserted source
Enrico Glaab

European Conference on Computational Biology: Ghent, BE

2010 | • ECCB 2010 Travel Fellowship Award to attend the European Conference on Computational Biology 2010
Distinction
Source: Self-asserted source
Enrico Glaab

Freunde der Saarbrücker Informatik e.V.: Saarbrücken, DE

2008 | Best Graduate Certificate ("Urkunde für herausragende Leistungen - bester Bioinformatik-Absolvent im Wintersemester 2007/08"
Distinction
Source: Self-asserted source
Enrico Glaab

Saarland University: Saarbrücken, DE

2006 | Member of the Honours Program for Graduate Students in Computer Science and Bioinformatics
Distinction
Source: Self-asserted source
Enrico Glaab

Studienstiftung des deutschen Volkes eV: Bonn, Nordrhein-Westfalen, DE

2005 | • Member of the German National Merit Foundation (Studienstiftung des Deutschen Volkes) during undergraduate and graduate education
Distinction
Source: Self-asserted source
Enrico Glaab

Saarland University: Saarbrücken, DE

2005 | • Scholarship from the Chair of Bioinformatics at Saarland University (1000 € stipend for the students with the three best results in the Bioinformatics I exam)
Distinction
Source: Self-asserted source
Enrico Glaab

Stiftung Jugend forscht: Hamburg, DE

2001 | • Winner of the national competition "Jugend forscht" ("Youth Researches") in the category Mathematics/Computer Science
Distinction
Source: Self-asserted source
Enrico Glaab

Eduard-Rhein Trust: Mayen, DE

2001 | Winner of the "Konrad Zuse Youth Prize" for Computer Science
Distinction
Source: Self-asserted source
Enrico Glaab

Funding (31)

Alpha-synuclein modifying protein interactors as targets for adjuvant therapy in Parkinson's disease

2025 to present | Grant
National Research Fund Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Unveiling the Epigenetic Landscape and Therapeutic Implications of Epigenetic Modifiers in Human T-cell Leukemia Initiation and Progression

2025 to present | Grant
National Research Fund Luxembourg (Luxembourg, Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Lecture Series on Causal Analysis of Biomedical Data

2024 to present | Grant
National Research Fund Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Towards druggable targets in Alzheimer’s disease through characterization of PLCG2-related pathways in neurons and microglia (AD-PLCG2)

2024 to 2027 | Grant
National Research Fund Luxembourg (Luxembourg, Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

PREdictive biomarkers in DYsTonia: defining the paradigm of monogenic dystonia to implement the diagnosis and prognosis of undiagnosed forms (PreDYT)

2023 to 2026 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, Esch-sur-Alzette, LU)
Source: Self-asserted source
Enrico Glaab

Rebalancing sleep-wake disturbances in Parkinson's Disease with deep brain stimulation (RECAST)

2023 to 2026 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Single cell characterization of pathological changes in Parkinson’s disease using human organoid models

2022 to present | Grant
Fondation Gustave et Simone Prévot (Genève, CH)
Source: Self-asserted source
Enrico Glaab

CLINNOVA: A Centre of Excellence in Digital Health and Personalised Healthcare

2022 to 2028 | Grant
Fonds National de la Recherche Luxembourg (Esch/Belval, LU)
URL: https://www.fnr.lu/clinnova-centre-excellence-digital-health-personalised-healthcare/
Source: Self-asserted source
Enrico Glaab

Molecular gender differences in Alzheimer’s disease

2022 to 2025 | Grant
Fondation Wivine Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Lecture Series on Digital Health and Digital Biomarkers

2022 to 2023 | Grant
Fonds National de la Recherche Luxembourg (Esch/Belval, LU)
Source: Self-asserted source
Enrico Glaab

inhibitPDE-RAS2: Assessment of new small molecule inhibitors of PDE6D for application in KRAS driven cancers

2021 to present | Grant
Fonds National de la Recherche (FNR) Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Validating DIGItal biomarkers for better personalized treatment of Parkinson’s Disease (DIGIPD)

2021 to present | Grant
Fonds National de la Recherche Luxembourg (Esch/Belval, LU)
Source: Self-asserted source
Enrico Glaab

Personalised medicine trials (PERMIT)

2020-01 to 2021-12 | Grant
European Commission (Brussels, BE)
URL: https://www.ecrin.org/activities/permit-project
Source: Self-asserted source
Enrico Glaab

Apolipoprotein E4 and Biological Gender: Finding new Entry Points for Precision Medicine in Alzheimer’s Disease

2020 to present | Grant
Jean Think Foundation (Wintrange, LU)
Source: Self-asserted source
Enrico Glaab

Combined in silico molecular docking and in vitro experimental assessment of drug repurposing candidates for COVID-19 (CovScreen)

2020 to present | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Metagenomics Diagnosis for Inflammatory Bowel Disease Challenge (MEDIC)

2020 to present | Award
SBV (Systems Biology Verification) IMPROVER challenge (New York, US)
Source: Self-asserted source
Enrico Glaab

Network-based machine learning analysis of chromatin changes in Parkinson's disease and Progressive Supranuclear Palsy

2019-06 to present | Award
Active Motif (Carlsbad, US)
Source: Self-asserted source
Enrico Glaab

Systems-level investigation of early molecular changes in Parkinson’s disease using miniaturized threedimensional human midbrain models

2019-06 to 2021 | Grant
Fondation Gustave et Simone Prévot (Genève, CH)
Source: Self-asserted source
Enrico Glaab

Analysis of injury-response genes in Alzheimer‘s disease

2018-12 to 2021-11 | Grant
Fondation Wivine Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

Multi-dimensional stratification of Parkinson’s disease patients for personalised interventions (PD-Strat)

2018-07 to 2021-06 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
GRANT_NUMBER:

11651464
Source: Self-asserted source
Enrico Glaab

MiRisk-PD: Mitochondrial Risk factors in Parkinson's disease

2018-03 to 2021-02 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
GRANT_NUMBER:

C17/BM/11676395
Source: Self-asserted source
Enrico Glaab

Analysing Molecular Heterogeneity of Microglia

2018 to present | Grant
Rotary Club Luxembourg (Luxexmbourg, LU)
Source: Self-asserted source
Enrico Glaab

Investigating modifiers of alpha-synuclein activity in iPSC-derived models of Parkinson’s disease

2017-01 to 2018-12 | Grant
Art2Cure (Luxembourg, LU)
GRANT_NUMBER:

I1R-NEU-PAU-15ART2
Source: Self-asserted source
Enrico Glaab

Validation of regulatory genes with putative relevance for Alzheimer’s disease

2017-01 to 2018-12 | Grant
Fondation Wivine Luxembourg (Luxembourg, LU)
GRANT_NUMBER:

I1R-DIR-PAU-15ABAD
Source: Self-asserted source
Enrico Glaab

Epigenetics-AD: Targeting epigenetic dysregulation in the brainstem in Alzheimer’s Disease

2016-01 to 2019-01 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
GRANT_NUMBER:

733051064
Source: Self-asserted source
Enrico Glaab

National Centre for Excellence in Research on Parkinson's Disease

2015-04 to 2019-03 | Grant
Fonds National de la Reserche Luxembourg (Esch-sur-Alzette, LU)
GRANT_NUMBER:

I1R-MSP-PFN-15NCER
Source: Self-asserted source
Enrico Glaab

MitoPD: Mitochondrial Endophenotypes of Parkinson’s Disease

2015-01 to 2018-01 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
GRANT_NUMBER:

I1R-EXB-PFN-13MIPD
Source: Self-asserted source
Enrico Glaab

Validation of regulatory genes with putative relevance for Alzheimer’s disease

2015 to 2017 | Grant
Fondation Wivine Luxembourg (Luxembourg, LU)
Source: Self-asserted source
Enrico Glaab

AlzUSP9: Involvement of the sex-linked gene USP9 in Alzheimer’s disease

2014-01 to 2015-12 | Grant
Geoffrey Beene Foundation Alzheimer’s Initiative (New York, US)
GRANT_NUMBER:

C2014002
Source: Self-asserted source
Enrico Glaab

Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target – ExPDIENT

2013-12 to 2016-05 | Grant
Fonds National de la Recherche Luxembourg (Luxembourg, LU)
GRANT_NUMBER:

C13/BM/5782168
Source: Self-asserted source
Enrico Glaab

Winner of the Alzheimer’s Global NeuroDiscovery Challenge

2013 to 2013 | Award
Geoffrey Beene Foundation Alzheimer’s Initiative (New York, US)
URL: http://geoffreybeenechallenge.org
GRANT_NUMBER: Alzheimer’s Global NeuroDiscovery Challenge
Source: Self-asserted source
Enrico Glaab

Peer review (123 reviews for 41 publications/grants)

Review activity for Alzheimer's research & therapy (1)
Review activity for Biodata mining. (1)
Review activity for Bioinformatics (34)
Review activity for BMC bioinformatics (6)
Review activity for BMC biology. (1)
Review activity for BMC medical genomics. (4)
Review activity for BMC systems biology. (4)
Review activity for Brain pathology. (2)
Review activity for Briefings in bioinformatics. (12)
Review activity for Cell death and disease. (1)
Review activity for Communications biology. (1)
Review activity for Computer methods and programs in biomedicine. (1)
Review activity for Computers in biology and medicine. (3)
Review activity for Drug discovery today. (1)
Review activity for eLife (1)
Review activity for European journal of neuroscience (1)
Review activity for Expert review of proteomics. (1)
Review activity for Genomics and computational biology. (1)
Review activity for Genomics. (1)
Review activity for IEEE transactions on evolutionary computation : (4)
Review activity for IEEE transactions on nanobioscience. (1)
Review activity for Journal of computational science. (1)
Review activity for Journal of heuristics. (1)
Review activity for Metabolic brain disease. (1)
Review activity for Metabolic brain disease. (2)
Review activity for Metabolites. (1)
Review activity for Metabolomics. (1)
Review activity for Molecular omics. (1)
Review activity for Molecular psychiatry. (1)
Review activity for Movement disorders. (1)
Review activity for Neural processing letters. (1)
Review activity for Neurobiology of disease. (1)
Review activity for Neuropsychiatric disease and treatment (1)
Review activity for NPJ Parkinson's disease. (1)
Review activity for Nucleic acids research. (15)
Review activity for PeerJ. (3)
Review activity for PeerJ. (2)
Review activity for PLoS computational biology. (2)
Review activity for PloS one. (3)
Review activity for Scientific reports. (1)
Review activity for UK Research and Innovation (1)
How many people are using ORCID?